|
Volumn 3, Issue 2, 2011, Pages 724-732
|
Omega 3 fatty acids- Clinical implications
|
Author keywords
Clinical implications; Omega 3 fatty acids
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CORTICOSTEROID;
DOCOSAHEXAENOIC ACID;
ETRETINATE;
HERBACEOUS AGENT;
ICOSAPENTAENOIC ACID;
LINOLENIC ACID;
LITHIUM;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
OMEGA 3 FATTY ACID;
POLYUNSATURATED FATTY ACID;
PSYCHOSTIMULANT AGENT;
S ADENOSYLMETHIONINE;
VITAMIN;
ARTICLE;
BONE DISEASE;
CARDIOVASCULAR DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CHEMICAL BOND;
CHEMICAL STRUCTURE;
DIABETES MELLITUS;
DIET SUPPLEMENTATION;
DIETARY INTAKE;
DRUG EFFECT;
DRUG FORMULATION;
FATTY ACID METABOLISM;
HUMAN;
HYPERICUM PERFORATUM;
NEOPLASM;
NONHUMAN;
PREGNANCY DISORDER;
PSORIASIS;
|
EID: 79955836638
PISSN: None
EISSN: 09744290
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (15)
|